Page 8 - Brain Bleeding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Based on clinical trials, more than a thousand adults and in the trial it was found that the drug appeared to reduce cognitive and functional decline by 27%. and that same trial we also saw some serious adverse events. 14% of people experienced adverse events compared with 11.3% who took a placebo. and some of the adverse events were a side effect and a small percentage of the group, including brain swelling and brain bleeding and some researchers have noticed that some people are at a certain genetic increased risk for those adverse events so depending on what the fda decision is this week we...

But we have to be cautious about it. >> while the data is encouraging, there were some safety concerns. brain swelling and brain bleeding. those are certainly things the fda will evaluate if the drug comes up for approval. number eight. mental health. in a cnn kff poll, 90% of adults believe there is a mental health crisis in the united states and another survey found nearly one in four adults age 18 to 44 were treated for mental health in 2021. reflecting an increased anxiety and depression during the pandemic. continuing concerns over mental health prompted the launch of a new three-digit na...

Or slowing of that clinical cognitive decline. they also looked at plaque in the brain. not surprisingly, the group that got the drug, the plaque decreased. >> still decline in cognitive ability but slower decline for people on the drug. >> that's right. >> the risks and side effects. important. >> always important to talk about this. we are always weighing and risks and benefits. there were some adverse side effects we should point out. the most common was infusion reactions. but they also saw increase in brain edema or swelling in the drug group compared to the placebo group, as well as brai...

Were some adverse side effects associated with the drug lecanemab that we should point out. the most to come was infusion reactions. but they also saw on increase in brain edema, or swelling in the lecanemab group as well as the bone group, as well as a brain hemorrhage or bleeding. most of these are mild and asymptomatic and got better, however, brain bleeding and swelling can cause headache, confusion, visual changes, hospitalization, and have a longer term impact. when you compare the overall adverse effects that were serious, again, higher percentage in the lecanemab group, more people dro...

So the two big questions are, well, that's good, no question, but is that enough to make a difference? will they be able to function better? will their families notice a difference? the second question is, what about the side effects? that's a serious question for this drugs. 17% of the people who took the drug on the study, 17% had brain bleeding. another 12% had brain swelling. now, to be clear, some of the folks who took the placebo had those two things, too, but nearly at rates that high. the media has reported on two deaths of the participants. the company said the deaths are not societie...